跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Fabrazyme ® 5mg (agalsidase beta) - HSA Drug Approval Details
Approvals
/
HSA
/
Fabrazyme ® 5mg (agalsidase beta)
Approved
STANDARD
Fabrazyme ® 5mg (agalsidase beta)
Unknown
🇸🇬 Health Sciences Authority
Approval Date
Jan 13, 2026
Approval ID
2fb1ffe3e8666bbf
Company
Unknown
Type
Standard
Approval Details
Approval Id
2fb1ffe3e8666bbf
Drug Name
Fabrazyme ® 5mg (agalsidase beta)
Active Ingredients
Agalsidase beta
5.5mg/5mg vial
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 13, 2026
Approval ID
2fb1ffe3e8666bbf
Type
Standard
Back to HSA Approvals